Neurogene Reports Positive Interim Data in Pediatric Cohort from NGN-401 Gene Therapy Trial for Rett Syndrome

Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced positive, ...

Stop using these outdated Linux commands before they cause problems

Linux offers many classic commands, but some are already outdated, insecure, or are now inefficient. We show you which ...

Where Art Meets Ease: UNICOS Elevates the Beauty Routine

From the effortless Eyelash Stamp to the Freckle Pen, UNICOS turns quick makeup moments into artful self-expression.LOS ...

The best free AI for coding in 2025 - only 3 make the cut now

I've been subjecting AI models to a set of real-world programming tests for over two years. This time, we look solely at the ...

Takeda Presents New Data Showing Mezagitamab (TAK-079) Sustained Effect on Kidney Function 18 Months After Treatment in Primary IgA Nephropathy

Takeda (TSE:4502/NYSE:TAK) today announced new interim data from the Phase 1b, open-label, proof-of-concept study of ...